Sarah Jurmeister - Concepedia

Author

Sarah Jurmeister

University of Cambridge ORCID

Also Known As

Jurmeister, Sarah, S Jurmeister, Sarah Jurmeister

Publications

649

Citations

H-Index

Concepts

All Affiliations

University of Cambridge Addenbrooke's Hospital Cancer Research UK Cancer Research UK Cambridge Center Universidade Estadual Paulista (Unesp)

About

Sarah Jurmeister is an author at University of Cambridge specializing in medicine, cell biology, and urology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	281
2	Cell Biology	3	3	281
3	Natural Sciences	1	1	27
4	Molecular Biology	1	1	27
5	Cancer Cell Biology	1	1	231

Sarah Jurmeister

Publications

647

Citations

H-Index

Page 1

	Year	Citations
MicroRNA-200c Represses Migration and Invasion of Breast Cancer Cells by Targeting Actin-Regulatory Proteins FHOD1 and PPM1F Sarah Jurmeister, Marek Baumann, Aleksandra Balwierz, Molecular and Cellular Biology Breast OncologyStress Fiber FormationActin-regulatory Proteins Fhod1Cancer BiologyMammary Gland Development	2011	231
A glycolytic phenotype is associated with prostate cancer progression and aggressiveness: a role for monocarboxylate transporters as metabolic targets for therapy Nelma Pértega‐Gomes, Sérgio Luís Felisbino, José R. Vizcaíno, The Journal of Pathology	2015	128
A lactate shuttle system between tumour and stromal cells is associated with poor prognosis in prostate cancer Nelma Pértega‐Gomes, José R. Vizcaíno, Jan Attig, BMC Cancer	2014	110
HES6 drives a critical <scp>AR</scp> transcriptional programme to induce castration‐resistant prostate cancer through activation of an <scp>E</scp> 2 <scp>F</scp> 1‐mediated cell cycle network Antonio Ramos‐Montoya, Alastair Lamb, Roslin Russell, EMBO Molecular Medicine	2014	84
Identification of potential therapeutic targets in prostate cancer through a cross‐species approach Sarah Jurmeister, Antonio Ramos‐Montoya, Chiranjeevi Sandi, EMBO Molecular Medicine	2018	44
Downregulation of Androgen Receptor Transcription by Promoter G-Quadruplex Stabilization as a Potential Alternative Treatment for Castrate-Resistant Prostate Cancer Antonio Ramos‐Montoya, Marco Di Antonio, Pierre Murat, Biochemistry Androgen ReceptorMolecular BiologyCastrate-resistant Prostate CancerTranscriptional RegulationDose-dependent Transcriptional Repression	2013	27
Transcriptomic analysis reveals inhibition of androgen receptor activity by AMPK in prostate cancer cells Sarah Jurmeister, Antonio Ramos‐Montoya, David E. Neal, Oncotarget Androgen ReceptorAndrogen Receptor ActivityUrologySignal TransductionSignaling Pathway	2014	23

Page 1